Current Drug Targets
Title:Editorial (Hot Topic: Neurodegeneration with Brain Iron Accumulation)
Volume: 13 Issue: 9
Author(s): Hiroaki Miyajima
Affiliation:
Export Options
About this article
Cite this article as:
Miyajima Hiroaki, Editorial (Hot Topic: Neurodegeneration with Brain Iron Accumulation), Current Drug Targets 2012; 13 (9) . https://dx.doi.org/10.2174/138945012802002339
DOI https://dx.doi.org/10.2174/138945012802002339 |
Print ISSN 1389-4501 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5592 |
12
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Recent Patents on Drugs Addressing Neurodegenerative Diseases
Recent Patents on Biomarkers Genomic and Pharmacogenomic Biomarkers of Parkinson’s Disease
Current Drug Metabolism The Effects of Vitamin B in Depression
Current Medicinal Chemistry Aceruloplasminemia
Current Drug Targets Vitamins and Cognition: A Nutrigenomics Perspective
Current Nutrition & Food Science Genetics and Pathophysiology of Neurodegeneration with Brain Iron Accumulation (NBIA)
Current Neuropharmacology Patent Selections
Recent Patents on CNS Drug Discovery (Discontinued) Mitochondria-Mediated Oxidative Stress: Old Target for New Drugs
Current Medicinal Chemistry Antimalarial Drugs and their Useful Therapeutic Lives: Rational Drug Design Lessons from Pleiotropic Action of Quinolines and Artemisinins
Current Drug Discovery Technologies Role of Vitamins in Neurodegenerative Diseases: A Review
CNS & Neurological Disorders - Drug Targets Novel Drug Targets in Malaria Parasite with Potential to Yield Antimalarial Drugs with Long Useful Therapeutic Lives
Current Pharmaceutical Design Consequences of Iron Accumulation in Microglia and its Implications in Neuropathological Conditions
CNS & Neurological Disorders - Drug Targets α-Synuclein Misfolding and Neurodegenerative Diseases
Current Protein & Peptide Science Maternal Choline Supplementation: A Potential Prenatal Treatment for Down Syndrome and Alzheimer’s Disease
Current Alzheimer Research Amine Oxidase Inhibitors and Development of Neuroprotective Drugs
Current Neuropharmacology Pantothenate Kinase-Associated Neurodegeneration
Current Drug Targets From Blood-to-Brain: Regulating the Permeability of the Blood-Brain Barrier
Current Psychopharmacology Influence of Vanin-1 and Catalytic Products in Liver During Normal and Oxidative Stress Conditions
Current Medicinal Chemistry A Genetic Dissection of Antipsychotic Induced Movement Disorders
Current Medicinal Chemistry Prevention and Treatment for Chemotherapy-Induced Peripheral Neuropathy: Therapies Based on CIPN Mechanisms
Current Neuropharmacology